Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6

Virology Journal

David Harrich¹  Ting Wei¹  Dongsheng Li¹  Hongping Jin¹  Vincent Cutillas¹  Ann Apolloni¹  Min-Hsuan Lin¹  Haran Sivakumaran¹ 

[1] Queensland Institute of Medical Research, Molecular Virology Laboratory, 300 Herston Road, Herston, Brisbane 4006, Australia

关键词: A549 cell line;    Protein methylation;    Protein arginine methyltransferase 6;    Tat;    HIV;   

Others  :  1149372
DOI  :  10.1186/1743-422X-10-207

 received in 2013-03-11, accepted in 2013-06-20,  发布年份 2013

【 摘 要 】

Background

Protein arginine methyltransferase 6 (PRMT6) can methylate the HIV-1 Tat, Rev and nucleocapsid proteins in a manner that diminishes each of their functions in in vitro assays, and increases the stability of Tat in human cells. In this study, we explored the relationship between PRMT6 and HIV-1 Tat by determining the domains in each protein required for interaction.

Methods

Through domain mapping and immunoprecipitation experiments, we determined that both the amino and carboxyl termini of PRMT6, and the activation domain within Tat are essential for interaction. Mutation of the basic domain of Tat did not affect the ability of PRMT6 to interact with Tat.

Results

We next used the A549 human alveolar adenocarcinoma cell line, which naturally expresses undetectable levels of PRMT6, as a model for testing the effects of PRMT6 on Tat stability, transactivation, and HIV-1 replication. As previously observed, steady state levels and the protein half-life of Tat were increased by the ectopic expression of PRMT6. However, no down regulation of Tat transactivation function was observed, even with over 300-fold molar excess of PRMT6 plasmid. We also observed no negative effect on HIV-1 infectivity when A549 producer cells overexpressed PRMT6.

Conclusions

We show that PRMT6 requires the activation domain, but surprisingly not the basic domain, of Tat for protein interaction. This interaction between Tat and PRMT6 may impact upon pathogenic effects attributed to Tat during HIV-1 infection other than its function during transactivation.

【 授权许可】

   
2013 Sivakumaran et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Wei P, Garber ME, Fang SM, Fischer WH, Jones KA: A novel CDK9-associated C-type cyclin interacts directly with HIV-1 tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998, 92:451-462.
• [2]Yang Z, Zhu Q, Luo K, Zhou Q: The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 2001, 414:317-322.
• [3]Barboric M, Lenasi T: Kick-sTARting HIV-1 transcription elongation by 7SK snRNP deporTATion. Nat Struct Mol Biol 2010, 17:928-930.
• [4]D'Orso I, Frankel AD: RNA-mediated displacement of an inhibitory snRNP complex activates transcription elongation. Nat Struct Mol Biol 2010, 17:815-821.
• [5]Hetzer C, Bisgrove D, Cohen MS, Pedal A, Kaehlcke K, Speyerer A, Bartscherer K, Taunton J, Ott M: Recruitment and activation of RSK2 by HIV-1 Tat. PLoS One 2007, 2:e151.
• [6]Yedavalli VR, Jeang KT: Methylation: a regulator of HIV-1 replication? Retrovirology 2007, 4:9. BioMed Central Full Text
• [7]Boulanger MC, Liang C, Russell RS, Lin R, Bedford MT, Wainberg MA, Richard S: Methylation of tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol 2005, 79:124-131.
• [8]Van Duyne R, Easley R, Wu W, Berro R, Pedati C, Klase Z, Kehn-Hall K, Flynn EK, Symer DE, Kashanchi F: Lysine methylation of HIV-1 tat regulates transcriptional activity of the viral LTR. Retrovirology 2008, 5:40. BioMed Central Full Text
• [9]Pagans S, Kauder SE, Kaehlcke K, Sakane N, Schroeder S, Dormeyer W, Trievel RC, Verdin E, Schnolzer M, Ott M: The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator tat, and enhances HIV transcription. Cell Host Microbe 2010, 7:234-244.
• [10]Sakane N, Kwon HS, Pagans S, Kaehlcke K, Mizusawa Y, Kamada M, Lassen KG, Chan J, Greene WC, Schnoelzer M, Ott M: Activation of HIV transcription by the viral tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1). PLoS Pathog 2011, 7:e1002184.
• [11]Hetzer C, Dormeyer W, Schnolzer M, Ott M: Decoding tat: the biology of HIV tat posttranslational modifications. Microbes Infect 2005, 7:1364-1369.
• [12]Xie B, Invernizzi CF, Richard S, Wainberg MA: Arginine methylation of the human immunodeficiency virus type 1 tat protein by PRMT6 negatively affects tat interactions with both cyclin T1 and the tat transactivation region. J Virol 2007, 81:4226-4234.
• [13]Sivakumaran H, van der Horst A, Fulcher AJ, Apolloni A, Lin MH, Jans DA, Harrich D: Arginine methylation increases the stability of human immunodeficiency virus type 1 tat. J Virol 2009, 83:11694-11703.
• [14]Wolf SS: The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans. Cell Mol Life Sci 2009, 66:2109-2121.
• [15]Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, Schuchlautz H, Luscher B, Amati B: Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007, 449:933-937.
• [16]Hyllus D, Stein C, Schnabel K, Schiltz E, Imhof A, Dou Y, Hsieh J, Bauer UM: PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev 2007, 21:3369-3380.
• [17]Iberg AN, Espejo A, Cheng D, Kim D, Michaud-Levesque J, Richard S, Bedford MT: Arginine methylation of the histone H3 tail impedes effector binding. J Biol Chem 2008, 283:3006-3010.
• [18]Kirmizis A, Santos-Rosa H, Penkett CJ, Singer MA, Vermeulen M, Mann M, Bahler J, Green RD, Kouzarides T: Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 2007, 449:928-932.
• [19]Invernizzi CF, Xie B, Richard S, Wainberg MA: PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA. Retrovirology 2006, 3:93. BioMed Central Full Text
• [20]Invernizzi CF, Xie B, Frankel FA, Feldhammer M, Roy BB, Richard S, Wainberg MA: Arginine methylation of the HIV-1 nucleocapsid protein results in its diminished function. AIDS 2007, 21:795-805.
• [21]Frankel A, Yadav N, Lee J, Branscombe TL, Clarke S, Bedford MT: The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J Biol Chem 2002, 277:3537-3543.
• [22]Kuppuswamy M, Subramanian T, Srinivasan A, Chinnadurai G: Multiple functional domains of tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res 1989, 17:3551-3561.
• [23]Garcia JA, Harrich D, Pearson L, Mitsuyasu R, Gaynor RB: Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat. EMBO J 1988, 7:3143-3147.
• [24]Reddy MV, Desai M, Jeyapaul J, Prasad DD, Seshamma T, Palmeri D, Khan SA: Functional analysis of the N-terminal domain of tat protein of the human immunodeficiency virus type 1. Oncogene 1992, 7:1743-1748.
• [25]Ruben S, Perkins A, Purcell R, Joung K, Sia R, Burghoff R, Haseltine WA, Rosen CA: Structural and functional characterization of human immunodeficiency virus tat protein. J Virol 1989, 63:1-8.
• [26]Pontius JU, Wagner L, Schuler GD: UniGene: a unified view of the transcriptome. In The NCBI Handbook. Edited by McEntyre J, Ostell J, Bethesda MD. : National Center for Biotechnology Information; 2003.
• [27]Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973, 51:1417-1423.
• [28]Menezes J, Leibold W, Klein G, Clements G: Establishment and characterization of an epstein-barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African burkitt's lymphoma. Biomedicine 1975, 22:276-284.
• [29]Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
• [30]El-Andaloussi N, Valovka T, Toueille M, Steinacher R, Focke F, Gehrig P, Covic M, Hassa PO, Schar P, Hubscher U, Hottiger MO: Arginine methylation regulates DNA polymerase beta. Mol Cell 2006, 22:51-62.
• [31]Michaud-Levesque J, Richard S: Thrombospondin-1 is a transcriptional repression target of PRMT6. J Biol Chem 2009, 284:21338-21346.
• [32]Zhang X, Cheng X: Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure 2003, 11:509-520.
• [33]Zhang J, Tamilarasu N, Hwang S, Garber ME, Huq I, Jones KA, Rana TM: HIV-1 TAR RNA enhances the interaction between tat and cyclin T1. J Biol Chem 2000, 275:34314-34319.
• [34]Sobhian B, Laguette N, Yatim A, Nakamura M, Levy Y, Kiernan R, Benkirane M: HIV-1 tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol Cell 2010, 38:439-451.
• [35]Dove BK, Surtees R, Bean TJ, Munday D, Wise HM, Digard P, Carroll MW, Ajuh P, Barr JN, Hiscox JA: A quantitative proteomic analysis of lung epithelial (A549) cells infected with 2009 pandemic influenza a virus using stable isotope labelling with amino acids in cell culture. Proteomics 2012, 12:1431-1436.
• [36]Yoshimatsu M, Toyokawa G, Hayami S, Unoki M, Tsunoda T, Field HI, Kelly JD, Neal DE, Maehara Y, Ponder BA, et al.: Dysregulation of PRMT1 and PRMT6, type I arginine methyltransferases, is involved in various types of human cancers. Int J Cancer 2011, 128:562-573.
• [37]Ott M, Emiliani S, Van Lint C, Herbein G, Lovett J, Chirmule N, McCloskey T, Pahwa S, Verdin E: Immune hyperactivation of HIV-1-infected T cells mediated by tat and the CD28 pathway. Science 1997, 275:1481-1485.
• [38]Ott M, Schnolzer M, Garnica J, Fischle W, Emiliani S, Rackwitz HR, Verdin E: Acetylation of the HIV-1 tat protein by p300 is important for its transcriptional activity. Curr Biol 1999, 9:1489-1492.
• [39]Arya SK, Guo C, Josephs SF, Wong-Staal F: Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 1985, 229:69-73.
• [40]Rayne F, Debaisieux S, Yezid H, Lin YL, Mettling C, Konate K, Chazal N, Arold ST, Pugniere M, Sanchez F, et al.: Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 tat by infected T-cells. EMBO J 2010, 29:1348-1362.
• [41]Johri MK, Mishra R, Chhatbar C, Unni SK, Singh SK: Tits and bits of HIV tat protein. Expert Opin Biol Ther 2011, 11:269-283.
• [42]Meredith LW, Sivakumaran H, Major L, Suhrbier A, Harrich D: Potent inhibition of HIV-1 replication by a tat mutant. PLoS One 2009, 4:e7769.
• [43]Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
• [44]King J, Laemmli UK: Polypeptides of the tail fibres of bacteriophage T4. J Mol Biol 1971, 62:465-477.